| Issue | Title | |
| No 1 (2012) | Фармакоэкономический анализ применения Гемопюра® в условиях плановых ортопедических операций | Abstract PDF (Rus) |
| , , , | ||
| No 4 (2021) | Подводя итоги: 20 лет журналу «Качественная клиническая практика» | Abstract PDF (Rus) |
| E. V. Afanasyeva | ||
| No 3 (2024) | «Declared quality of life»: new perspectives for assessing patients’ quality of life in clinical medicine | Abstract PDF (Rus) |
| Yu. A. Sukhonos, T. P. Nikitina, N. Yu. Sukhonos, T. I. Ionova | ||
| No 4 (2019) | Clostridium difficile associated infection: view of hospital-based health technology assessment | Abstract PDF (Rus) |
| Y. M. Gomon | ||
| No 1 (2011) | 10 лет нелёгкого пути... | Abstract PDF (Rus) |
| No 1 (2016) | 15 years of «Good clinical practice» journal | Details PDF (Rus) |
| U. B. Belousov | ||
| No 2 (2022) | A logistic regression-based model to predict ICU mortality: problems and solutions | Abstract PDF (Rus) |
| A. S. Luchinin, A. V. Lyanguzov | ||
| No 4 (2016) | A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia | Abstract PDF (Rus) |
| I. S. Krysanov, V. Yu. Ermakova | ||
| No 3 (2021) | A social-economic burden of rhinosinusitis with nasal polyps with comorbid asthma and influence of dupilumab | Abstract PDF (Rus) |
| I. S. Krysanov, V. S. Krysanova, V. Yu. Ermakova | ||
| No 1 (2017) | Actual questions of treatment of urinary tract infection in neonates | Abstract PDF (Rus) |
| S. K. Zyryanov, O. A. Shulakova, K. G. Gurevich | ||
| No 3 (2017) | Adaptive design in clinical trials: benefits and risks | Abstract PDF (Rus) |
| I. B. Bondareva | ||
| No 1 (2022) | Ademetionine treatment cost analysis of patients with intrahepatic cholestasis and non-alcoholic fatty disease | Abstract PDF (Rus) |
| M. V. Zhuravleva, G. V. Kukushkin, E. V. Luchinina, T. V. Shelekhova, T. R. Kameneva, E. V. Kuznetsova, E. A. Luchinin | ||
| No 4S (2020): PharmaCOVID | Adjusting the role of hydroxychloroquine with or without azithromycin in patients with COVID-19 | Abstract PDF (Rus) |
| V. A. Otdelenov, Yu. Yu. Kiselev, K. B. Mirzaev, A. V. Matveev, D. A. Sychev | ||
| No 1 (2024) | Adverse drug events among hospitalized COVID-19 patients. Experience with the Global Trigger Tool | Abstract PDF (Rus) |
| S. A. Mishinova, A. S. Kolbin, E. V. Verbitskaya, N. P. Alekseeva, Yu. M. Gomon | ||
| No 4 (2022) | Adverse reactions of high-osmolar and low-osmolar radiographic contrast media in clinical practice | Abstract PDF (Rus) |
| G. A. Batischeva, O. A. Zhdanova, N. N. Perova, T. E. Kotelnikova, N. Y. Goncharova, K. A. Ryaskin | ||
| No 2 (2021) | Alcohol as a risk factor for drug-induced diseases | Abstract PDF (Rus) |
| D. A. Sychev, O. D. Ostroumova, A. P. Pereverzev, A. I. Kochetkov, T. M. Ostroumova, E. Yu. Ebzeeva, M. V. Klepikova | ||
| No 3 (2023) | An economic evaluation of vaccination in children against meningococcal infection in Moscow | Abstract PDF (Rus) |
| S. V. Svetlichnaya, L. N. Mazankova, L. D. Popovich, L. A. Elagina | ||
| No 4 (2018) | An update of pharmacoeconomic analysis of trastuzumab emtanzine in patients with HER2+ breast cancer and central nervous system metastases | Abstract PDF (Rus) |
| A. S. Kolbin, A. A. Kurylev, Y. E. Balykina, M. A. Proskurin | ||
| No 1 (2019) | Analysis of antithrombotic therapy of atrial fibrillation in international and Russian registries | Abstract PDF (838 кбайт) (Rus) |
| O. V. Reshetko, A. V. Sokolov, N. V. Furman | ||
| No 2 (2021) | Analysis of associations between pharmacodynamic genetic factors and antipsychotics’ effectiveness and safety in adolescents with acute psychotic episodes taking antipsychotics during a 28-day follow-up | Abstract PDF (Rus) |
| D. V. Ivaschenko, L. V. Fedina, N. I. Buromskaya, P. V. Shimanov, R. V. Deitsch, M. I. Nastovich, K. A. Akmalova, A. A. Kachanova, E. A. Grishina, L. M. Savchenko, Y. S. Shevchenko, D. A. Sychev | ||
| No 1 (2014) | Analysis of drug purchases aft er the entry into force of the federal contract system | Abstract PDF (Rus) |
| M. G. Malaev | ||
| No 1 (2014) | Analysis of drugs procurement to ensure the provision of medical care in hospitals | Abstract PDF (Rus) |
| M. G. Malaev | ||
| No 3 (2017) | Analysis of effectiveness criteria in pharmacoeconomic studies of hypoglycemic drugs proposed for inclusion into the essential drug list in 2014-2016 in Russia | Abstract PDF (Rus) |
| A. A. Mosikyan, A. A. Kurylev, A. S. Kolbin | ||
| No 3 (2024) | Analysis of spontaneous reports from a pediatric population: Stevens–Johnson syndrome and toxic epidermal necrolysis induced by antibacterial drugs | Abstract PDF (Rus) |
| Yu. O. Kustov, E. N. Terekhina, I. L. Asetskaya, O. I. Butranova | ||
| 1 - 24 of 679 Items | 1 2 3 4 5 6 7 8 9 10 > >> | |
Browse Title Index
НАШИ КНИГИ
Другие журналы
"Издательства ОКИ"
ПАРТНЕРЫ
Popular articles
No 2 (2023)
No 4 (2023)
Efficacy of interleukin-6 inhibitors as a tool for preventive anti-inflammatory therapy for COVID-19
No 1 (2024)
No 3 (2024)
Keywords
COVID-19
QALY
adverse drug reactions
budget impact analysis
coronavirus
cost-effectiveness analysis
cost-utility analysis
drugs
health technology assessment
pharmacoeconomics
pharmacovigilance
анализ влияния на бюджет
анализ затраты-эффективность
анализ минимизации затрат
анализ эффективности затрат
артериальная гипертония
качество жизни
клинические исследования
фармаконадзор
фармакоэкономика
фармакоэпидемиология
115522, Moscow, Russian Federation, Moskvorechye str. 4-5-129
LLC "Publishing House OKI"
Tel. +7 (910) 449-22-73
e-mail: clinvest@mail.ru
